Efficacy and Safety of Ravulizumab in IgAN: Week 50 Results from a Phase 2 Randomized Controlled Trial

Autor: Tumlin, James A., Lafayette, Richard A., Barratt, Jonathan, Wu, Mai-Szu, Kim, Sung Gyun, Kaufeld, Jessica Katharina, Huang, Shih-Han S., Alamartine, Eric, Pérez valdivia, Miguel angel, Rice, Kara, Kateifides, Andreas, Garlo, Katherine, Roccatello, Dario
Zdroj: Journal of the American Society of Nephrology; October 2024, Vol. 35 Issue: 10, Number 10 Supplement 10
Databáze: Supplemental Index